期刊文献+

海绵抗肿瘤活性成分的临床试验研究进展 被引量:1

原文传递
导出
摘要 恶性肿瘤是威胁人类生命引发死亡的重要因素,近年来从天然产物中分离提取新型抗肿瘤先导化合物成为新药创制的研究热点[1-2]。海洋生物物种的多样性及其生存环境的高盐、高温、高压等特殊性,为新药开发提供了许多结构新颖的先导化合物,表现出显著的抗肿瘤、
出处 《中南药学》 CAS 2013年第6期447-450,共4页 Central South Pharmacy
基金 国家"重大新药创制"科技重大专项(No.2012ZX09303014-001) 国家国际科技合作计划(No.2011DFA30620)
  • 相关文献

参考文献29

  • 1Tadeusz F Molinski, Doralyn S Dalisay, Sarah L Lievens, et al. Drug development from marine natural products [J]. Nat Rev Drug Discov, 2009, 8 (1) : 69-85.
  • 2VA Stonik. Marine natural products: a way to new drugs [J]. Acta Naturae, 2009, 1 (2) : 15-25.
  • 3Sunil Sagar, Mandeep Kaur, Kenneth P Minneman. Antiviral lead compounds from marine sponges [J]. Mar Drugs, 2010, 8 (10) : 2619-2638.
  • 4Chambers C Hughes, William Fenical. Antibacterials from the sea [J]. Chemistry, 2010, 16 (42) : 12512-12525.
  • 5Alejandro MS Mayer, Kirk R Gustafson. Marine pharmacology in2003-2004: anti-tumour and cytotoxic compounds [J]. Eur J Can- cer, 2006, 42 (14) : 2241-2270.
  • 6Alejandro MS Mayer, Kirk R Gustafson. Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds [J]. Eur J Can- cer, 2008, 44 (16) : 2357-2387.
  • 7Magbubah Essack, Vladimir B Bajic, John AC Archer. Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment [J]. Mar Drugs, 2011, 9 (9) : 1580-1606.
  • 8David J Newman, Gordon M Cragg. Marine natural products and related compounds in clinical and advanced preclinical trials [J]. J NatProd, 2004, 67 (8) : 1216-1238.
  • 9Sarah L Scarpace, Pharm D, BCOP. Eribulin mesylate ( E7389 ) : review of efficacy and tolerability in breast, pancreatic, head and neck, and non-small cell lung cancer [J]. Clin Ther, 2012, 34( 7 ): 1467-1473.
  • 10Antonio Jimeno. Eribulin: rediscovering tubulin as an anticancer target [J]. ClinCancerRes, 2009, 15 ( 12 ) : 3903-3905.

同被引文献29

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部